Recombinant Human CA125/MUC16 Protein, Active
Beta LifeScience
SKU/CAT #: BLK-00493P-100UG

Human CA125 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human CA125/MUC16 Protein, Active
Beta LifeScience
SKU/CAT #: BLK-00493P-100UG
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human CA125/MUC16 Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Asp12783-Ser13467. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | Q8WXI7 |
Target Symbol | CA125/MUC16 |
Species | Human |
Expression System | HEK293 |
Tag | C-His |
Expression Range | Asp12783-Ser13467 |
Mol. Weight | The protein has a predicted MW of 76.17 kDa. Due to glycosylation, the protein migrates to 90-140 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized Human CA125, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Human MSLN, hFc Tag with the EC50 of 7.8ng/ml determined by ELISA. Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | MUC16, also known as the CA125 antigen, is a mucin protein that may be found in type I transmembrane or secreted forms that are used monitor the progress of epithelial ovarian cancer therapy.Thought to provide a protective, lubricating barrier against particles and infectious agents at mucosal surfaces.Binding to MSLN mediates heterotypic cell adhesion. This may contribute to the metastasis of ovarian cancer to the peritoneum by initiating cell attachment to the mesothelial epithelium via binding to MSLN. |